首页> 外文期刊>Analytical methods >Simultaneous determination of ginkgolides A, B and K in human plasma by UPLC-MS/MS and its application to the pharmacokinetic study of Ginkgo Diterpene Lactone Meglumine Injection in humans
【24h】

Simultaneous determination of ginkgolides A, B and K in human plasma by UPLC-MS/MS and its application to the pharmacokinetic study of Ginkgo Diterpene Lactone Meglumine Injection in humans

机译:UPLC-MS / MS同时测定人血浆中银杏内酯A,B和K的方法及其在银杏双萜内酯葡甲胺注射剂体内药代动力学研究中的应用

获取原文
           

摘要

We developed and validated a rapid, selective and sensitive ultra-performance liquid-chromatography mass-spectrometry (UPLC-MS/MS) method for quantifying ginkgolide A, ginkgolide B and ginkgolide K as hydrolyzed forms in Ginkgo Diterpene Lactone Meglumine Injection (manufactured by Jiangsu Kanion Pharmaceutical Co., Ltd., Lianyungang, Jiangsu, China) for pharmacokinetic studies. Three ginkgolide compounds and internal-standard (IS), bilobalide, were extracted from human plasma by liquida€“liquid extraction using ethyl acetate after acidification, and were separated on an Ace C18-AR column (2.1 mm ?— 50 mm, 3 ??m) using a mobile phase of water containing 20 mM ammonium formate (adjusting pH to 5.4 using formic acid) and acetonitrile by gradient elution. Quantification was performed using negative-ion electrospray-ionization (ESI), and the content of ginkgolides was determined using multiple reaction monitoring (MRM) modes. Pharmacokinetics was assessed after intravenous infusion administration of Ginkgo Diterpene Lactone Meglumine Injection (containing 25 mg ginkgolides) to 3 healthy male Chinese volunteers. Analysis of the standard curves by linear regression revealed a high linearity over a 100-fold dynamic range for the three ginkgolides (the lower limit of quantitation values were 0.189a€“0.200 ng mLa?’1). The relative standard deviations of intra- and inter-day measurements were less than 10.7%, and accuracies were between a?’4.6% and 12.3% in terms of relative error; the extraction recoveries from human plasma were 89.4a€“91.9%, 81.0a€“85.0% and 78.5a€“82.5% for ginkgolide A, ginkgolide B and ginkgolide K, respectively. In conclusion, UPLC-MS/MS is rapid and sensitive for simultaneous quantification of multiple ginkgolides from Ginkgo Diterpene Lactone Meglumine Injection in human plasma and is suitable for pharmacokinetic studies.
机译:我们开发并验证了一种快速,选择性和灵敏的超高效液相色谱质谱(UPLC-MS / MS)方法,用于定量测定银杏二萜内酯葡甲胺注射液中水解形式的银杏内酯A,银杏内酯B和银杏内酯K(江苏制造) Kanion Pharmaceutical Co.,Ltd.(江苏连云港),用于药代动力学研究。酸化后,用乙酸乙酯通过液相萃取从人血浆中提取出三种银杏内酯化合物和内标(IS)银杏内酯,并在Ace C18-AR色谱柱上分离(2.1 mm×50 mm,3 mm)。使用含有20 mM甲酸铵的水(使用甲酸将pH调节至5.4)和乙腈的流动相通过梯度洗脱。使用负离子电喷雾电离(ESI)进行定量,并使用多种反应监测(MRM)模式确定银杏内酯的含量。在向3名健康的中国男性志愿者静脉输注银杏双萜内酯葡甲胺注射液(含25 mg银杏内酯)后评估了药代动力学。通过线性回归分析标准曲线,发现三种银杏内酯在100倍动态范围内具有很高的线性(定量下限为0.189a?0.200 ng mLa?-1)。日内和日间测量的相对标准偏差小于10.7%,相对误差的准确度在a?4.6%和12.3%之间;银杏内酯A,银杏内酯B和银杏内酯K的人血浆提取回收率分别为89.4aa91.9%,81.0a€85.0%和78.5a€82.5%。总之,UPLC-MS / MS快速,灵敏,可同时定量测定人血浆中银杏双萜内酯葡甲胺注射液中多种银杏内酯,适用于药代动力学研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号